Medifast (MED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Imperial Capital Downgrades Medifast (MED) to In-Line
November 7, 2014 6:45 AM ESTImperial Capital downgraded Medifast (NYSE: MED) from Outperform to In-Line with a price target of $32.00 (from $34.00).
Analyst Mitchell Pinheiro comments, "Our price target is about 3% below the recent share price. Our In-Line rating is based on our lower earnings forecast for 2015 which incorporates more subdued growth in the Take Shape For Life segment, the expectation for a flat... More
